SynBioBeta (Synthetic Biology Summit)

Overview

Hosts an annual synthetic biology summit with conference sessions, speakers, passes, and exhibit hall participation for biotech attendees, companies, sponsors, and exhibitors.

Part of the Silicon Valley ecosystem

Related

• 8VCBuilds and invests in technology companies, partnering with entrepreneurs to develop platforms addressing areas such as healthcare, zero-emission aircraft, privacy enforcement, and urban tunneling.
• ARCH Venture PartnersBuilds and backs science-based companies, investing flexibly in portfolio businesses founded around technologies intended to affect human health and disease.
• CellaresDevelops and operates automated cell therapy manufacturing technologies and services, helping therapy developers transfer production and analytical processes into cGMP-compliant systems.
• Chai DiscoveryBuilds computer-aided molecular design software that models biochemical structure and interaction, helping scientists design new medicines and molecules on computers.
• In-Q-TelBuilds a nonprofit investment platform that identifies strategic technology startups and adapts their technologies to meet current and future government partner mission needs.
• IndieBioProvides onsite biolabs and pre-seed investment for scientists launching startups across biotech, food, agriculture, industrial decarbonization, AI, therapeutics, and diagnostics.
• InsitroBuilds AI systems using automated cellular experiments and population genetics to identify causal disease targets and design therapeutics across multiple drug modalities.
• NewLimitDevelops medicines using AI-designed payloads and genomics testing to restore youthful function in old cells, targeting age-related cellular decline and human healthspan.
• Numerion LabsBuilds an AI platform that searches chemical space for novel drug-like molecules, supporting small-molecule drug discovery programs for immune and inflammatory diseases.
• ProfluentBuilds AI systems that design proteins from natural scaffolds or from scratch for therapeutic, industrial enzyme, and other protein design applications.
• Scribe TherapeuticsEngineers CRISPR-based therapeutics by modifying natural CRISPR systems, with treatments focused on cardiometabolic disease and collaborations extending the approach to other therapeutic areas.
• Stanford UniversityEducates students, conducts interdisciplinary research, develops technologies, supports human health, and applies policy work to address societal needs and benefit humanity.